Valcon Medical Announces First Dispatch of EU-Certified Medical Cannabis Extracts and Standardised Oils to Germany
The first dispatch of EU-certified medical cannabis extracts and standardised oils to Germany highlights Valcon Medical's poised to significantly impact the medical cannabis industry and the lives of chronic patients.
COPENHAGEN, DENMARK, August 25, 2022 - Valcon Medical, a leading global provider of medical cannabis products, is pleased to announce the successful dispatch of its first shipment of EU-certified medical cannabis extracts and standardised oils to Germany. This milestone marks a significant step forward in Valcon Medical's mission to provide high-quality medical cannabis products to patients in need.
Germany, known for its stringent regulatory framework surrounding medical cannabis, has established itself as a key market for the industry. The country legalised medical cannabis in 2017, allowing patients with certain conditions to access cannabis-based treatments under strict regulations. The regulatory framework ensures that patients receive safe and effective medical cannabis products while maintaining control over the supply chain.
Under the German regulatory framework, medical cannabis products must meet specific quality standards and undergo rigorous testing before they can be prescribed to patients. Valcon Medical is proud to have obtained EU-GMP-certification for its medical cannabis extracts and standardised oils, ensuring compliance with the highest quality and safety standards.
The dispatch of Valcon Medical's EU-certified medical cannabis extracts and standardised oils to Germany is a significant achievement for the company. It demonstrates Valcon Medical's commitment to providing patients with reliable and effective medical cannabis treatments, backed by scientific research and stringent quality control measures.
According to recent statistics, the demand for medical cannabis extracts in Germany has been steadily increasing. In 2020 alone, over 142,000 prescriptions for medical cannabis extracts were issued, representing a significant rise compared to previous years. This surge in demand highlights the growing acceptance and recognition of medical cannabis as a viable treatment option for various medical conditions.
Valcon Medical is dedicated to meeting the rising demand for medical cannabis extracts in Germany and beyond. By leveraging its expertise in extraction, and product development, the company aims to improve patients' quality of life and contribute to the advancement of medical cannabis research.
As Valcon Medical continues to expand its product offerings and distribution network, the company remains committed to upholding the highest standards of quality, safety, and compliance. With its first dispatch of EU-certified medical cannabis extracts and standardised oils to Germany, Valcon Medical is poised to make a significant impact on the medical cannabis industry and the lives of patients in need.
About Valcon Medical
Valcon Medical is a global provider of high-quality medical cannabis products. With a focus on research, extraction, and product development, Valcon Medical aims to improve patients' quality of life by providing safe and effective medical cannabis treatments. The company is committed to upholding the highest standards of quality, safety, and compliance in the medical cannabis industry.
